Additionally, USP14 inhibits the degradation of IκBα, thereby suppressing NFκB signalling and enhancing sensitivity to TNFα‐induced cell death in head and neck squamous cell carcinoma, offering a potential strategy to overcome TNFα resistance in these cancers [33]. Here, USP14 is linked to head and neck squamous cell carcinoma.